tiprankstipranks
Advertisement
Advertisement

CYTK Stock Latest News

MYQORZO’s Differentiated Superiority in oHCM and De‑Risked Pipeline Support Buy Rating on CYTK
RatingsMYQORZO’s Differentiated Superiority in oHCM and De‑Risked Pipeline Support Buy Rating on CYTK
2d ago
CYTK
Cytokinetics price target raised to $100 from $84 at Mizuho
PremiumThe Fly
Cytokinetics price target raised to $100 from $84 at Mizuho
14d ago
CYTK
JPMorgan ups Cytokinetics target, adds to Analyst Focus List
PremiumThe Fly
JPMorgan ups Cytokinetics target, adds to Analyst Focus List
15d ago
CYTK
Cytokinetics announces four presentations in obstructive HCM at ACC Expo
PremiumThe Fly
Cytokinetics announces four presentations in obstructive HCM at ACC Expo
16d ago
CYTK
Cytokinetics price target raised to $69 from $61 at UBS
PremiumThe Fly
Cytokinetics price target raised to $69 from $61 at UBS
26d ago
CYTK
Cytokinetics Earnings Call Marks High-Stakes Launch Phase
PremiumCompany AnnouncementsCytokinetics Earnings Call Marks High-Stakes Launch Phase
27d ago
CYTK
FDA Disruptions and Budget Cuts Pose Rising Regulatory Risk to Cytokinetics’ Drug Pipeline
Premium
Company Announcements
FDA Disruptions and Budget Cuts Pose Rising Regulatory Risk to Cytokinetics’ Drug Pipeline
1M ago
CYTK
Cytokinetics management to meet with B. Riley
Premium
The Fly
Cytokinetics management to meet with B. Riley
1M ago
CYTK
Cytokinetics price target raised to $67 from $66 at BofA
PremiumThe Fly
Cytokinetics price target raised to $67 from $66 at BofA
1M ago
CYTK
Cytokinetics price target raised to $98 from $95 at Stifel
PremiumThe Fly
Cytokinetics price target raised to $98 from $95 at Stifel
1M ago
CYTK
Cytokinetics: Strong Myqorzo Launch, Expanding Market Access, and Upcoming HCM Milestones Underpin Buy Rating
PremiumRatings
Cytokinetics: Strong Myqorzo Launch, Expanding Market Access, and Upcoming HCM Milestones Underpin Buy Rating
1M ago
CYTK
Cytokinetics price target raised to $96 from $88 at Citizens
PremiumThe Fly
Cytokinetics price target raised to $96 from $88 at Citizens
1M ago
CYTK
Cytokinetics (CYTK) Q4 Earnings Cheat Sheet
PremiumPre-EarningsCytokinetics (CYTK) Q4 Earnings Cheat Sheet
1M ago
CYTK
Cytokinetics price target raised to $101 from $95 at RBC Capital
Premium
The Fly
Cytokinetics price target raised to $101 from $95 at RBC Capital
1M ago
CYTK
Cytokinetics transferred with Overweight at Barclays
Premium
The Fly
Cytokinetics transferred with Overweight at Barclays
1M ago
CYTK
MYQORZO: EC Approval, Differentiated Label, and Global HCM Expansion Support Buy on CYTK
PremiumRatings
MYQORZO: EC Approval, Differentiated Label, and Global HCM Expansion Support Buy on CYTK
1M ago
CYTK
Cytokinetics Wins European Approval for MYQORZO in HCM
PremiumCompany Announcements
Cytokinetics Wins European Approval for MYQORZO in HCM
1M ago
8K
CYTK
Cytokinetics announces EC has approved Myqorzo for oHCM in adults
PremiumThe Fly
Cytokinetics announces EC has approved Myqorzo for oHCM in adults
1M ago
CYTK
Cytokinetics: Buy Rating on Myqorzo’s oHCM Opportunity and 2026 Commercial Inflection Catalysts
PremiumRatings
Cytokinetics: Buy Rating on Myqorzo’s oHCM Opportunity and 2026 Commercial Inflection Catalysts
2M ago
CYTK
Cytokinetics price target raised to $92 from $84 at Truist
PremiumThe FlyCytokinetics price target raised to $92 from $84 at Truist
2M ago
CYTK
Cytokinetics price target raised to $66 from $65 at BofA
Premium
The Fly
Cytokinetics price target raised to $66 from $65 at BofA
2M ago
CYTK
Cytokinetics assumed with an Overweight at Barclays
Premium
The Fly
Cytokinetics assumed with an Overweight at Barclays
2M ago
CYTK

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >